PolyNovo Limited (ASX: PNV) has reported a pick-up in sales, due to which December 2019 was the first two-million-dollar month for the company .
- Unaudited revenue from NovoSorb BTM sales achieved the $2 million mark, compared with $890k in previous corresponding period;
- Unaudited half-year revenues from NovoSorb BTM were $8.57 million against $3.75 million in the previous corresponding period;
The company has also advised that the sales will continue to be lumpy as new sales staff are added and new territories opened up and because of natural disasters such as fires and volcanoes.
By 12:51 PM AEDT, PNV was trading at $1.94, up by 6.88 per cent from the previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.